00:00
00:00
00:00
Suda takes full control of ArTiMist

SUDA LTD (ASX: SUD) (SUDA), a leader in oro mucosal drug delivery, is pleased to announce the acquisition of the 20% minority shareholding in SUDA’s subsidiary company, Malaria Research Company Pty Ltd (MRC), which was owned by UK based ProtoPharma Ltd (PPL) and its parent London Pharma Ltd (LPL).

Stephen Carter, CEO
CEO

Company Events - SUDA LTD